Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Abstract. Background: So far, planning of clinical trials in multiple myeloma (MM) has been based on traditional outcome measures such as progression free (PFS)

  • A substantial minority of patients would prefer PFS over Quality of life in the maintenance setting.